Serological diagnosis of idiopathic pulmonary alveolar proteinosis

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 2 I, 2000, Pages 658-662

  Kitamura, T ^a   Uchida, K ^a   Tanaka, N ^a   Tsuchiya, T ^a   Watanabe, J ^a   Yamada, Y ^a   Hanaoka, K ^a   Seymour, J F ^a   Schoch, O D ^a   Doyle, I ^a   Inoue, Y ^a   Sakatani, M ^a   Kudoh, S ^a   Azuma, A ^a   Nukiwa, T ^a   Tomita, T ^a   Katagiri, M ^a   Fujita, A ^a   Kurashima, A ^a   Kanegasaki, S ^a   Nakata, K ^a   more..

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IODINE 125;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; HUMAN; LUNG ALVEOLUS PROTEINOSIS; MALE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RELIABILITY; SERODIAGNOSIS;

EID: 0033841354     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.2.9910032     Document Type: Article

References (18)

1. The pulmonary surfactant system: Biochemical aspect and functional significance
2. Pulmonary surfactant protein
3. Bronchoalveolar lavage fluids composition in alveolar proteinosis: Early changes after therapeutic lavage
4. Degradation of pulmonary surfactant desaturated phosphatidylcholines by alveolar macrophages
5. Surfactant protein A is degraded by alveolar macrophages
6. Degradation of surfactant protein D by alveolar macrophages
7. Diagnosing pulmonary alveolar proteinosis: A review and an update
8. Alveolar proteinosis: Importance of pulmonary lavage
9. Serum and bronchoalveolar fluid KL-6 levels in patients with pulmonary alveolar proteinosis
10. Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte-macrophage colony stimulating factor
11. Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor
12. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
13. Establishent and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin
14. Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations
15. Induction of anti-recombinant human granulocyte-macrophage colony-stimulating factor (Escherichia coli-derived) antibodies and clinical effects in nonimmunocompromised patients
16. Production of neutralizing granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in carcinoma patients following GM-CSF combination therapy